It might be a bit late, but the supply will come on tap eventually. France’s Sanofi has partnered with Pfizer to start manufacturing its vaccine. BioNTech has just bought a factory in Marburg, Germany from Switzerland’s drugs giant Novartis to retrofit into a vaccine plant. With plenty of money being splashed around, production will arrive soon. Making vaccines is tricky, but not that tricky. By the summer, Europe should have enough Covid-19 shots to jab everyone who wants one.
Crisis over, right? Ursula von der Leyen can get back to setting diversity targets, or making climate pledges, or whatever it was she was up to before people started asking why the Israelis and the British were inoculating people so much faster than she was. While Stella Kyriakides, the EU heath commissioner, can slink back to the relative obscurity of Cypriot politics. The whole saga will blow over, and everyone can get back to normal.
Comments
Join the debate for just $5 for 3 months
Be part of the conversation with other Spectator readers by getting your first three months for $5.
UNLOCK ACCESS Just $5 for 3 monthsAlready a subscriber? Log in